The SafeBoosC II randomized trial: treatment guided by near-infrared spectroscopy reduces cerebral hypoxia without changing early biomarkers of brain injury.
Anne M PlomgaardWim van OeverenTue H PetersenThomas AlderliestenTopun AustinFrank van BelManon J N L BendersOlivier ClarisEugene DempseyAxel R FranzMonica FumagalliChristian GluudCornelia HagmannSimon Hyttel-SorensenPetra LemmersAdelina PellicerGerhard PichlerPer WinkelGorm GreisenPublished in: Pediatric research (2015)
Treatment guided by NIRS reduced the cerebral burden of hypoxia without affecting EEG or the selected blood biomarkers.